Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
about
Neural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot studyMammalian nicotinic acetylcholine receptors: from structure to functionSynaptic plasticity in animal models of early Alzheimer's diseaseMemantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's diseaseNicotinic ACh receptors as therapeutic targets in CNS disordersInositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membraneBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseBeneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated ratsCholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's diseaseEvidence of association between sleep quality and APOE ε4 in healthy older adults: A pilot studyReduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in miceThe avian subpallium: new insights into structural and functional subdivisions occupying the lateral subpallial wall and their embryological originsAllosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.Can zebrafish be used as animal model to study Alzheimer's disease?Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.Distinct roles of basal forebrain cholinergic neurons in spatial and object recognition memoryReal-time imaging of single nerve cell apoptosis in retinal neurodegeneration.Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortexMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer diseaseAssessment of neuroprotection in the retina with DARC.Small molecule activators of the Trk receptors for neuroprotectionGenetically-directed, cell type-specific sparse labeling for the analysis of neuronal morphologyPreservation of cortical sortilin protein levels in MCI and Alzheimer's disease.Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain.Estrogen therapy and cognition: a review of the cholinergic hypothesisNicotinic mechanisms influencing synaptic plasticity in the hippocampus.Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic miceAlzheimer's disease is type 3 diabetes-evidence reviewed.Synthesis and characterization of luminescent cadmium selenide/zinc selenide/zinc sulfide cholinomimetic quantum dots.Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors.Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's diseasePinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsApolipoprotein E: from lipid transport to neurobiologyImmunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
P2860
Q24596119-FF91B642-85D4-4394-A540-95ABC8106C6EQ24647069-653EC025-5C28-4F8E-8399-DF694B256059Q24675772-04F19C8A-9928-4145-8D59-495E0BF38532Q27025207-C7B35AAE-A316-4C86-B34D-047D1E873B0AQ28111941-58B3D436-2AE4-41A1-A275-A6384218622BQ28187990-FBDD16FD-8051-4D9E-88E3-89BA555D89BCQ28257015-A9578235-BBAE-4735-988B-7067D89585DEQ28259585-4BF54C88-53C8-40FB-95A8-458C7D060B13Q28284594-0D613A4A-53AC-4573-BF32-D1495D774B42Q28287090-C1754D5A-C381-4D1B-8324-71F8B7D369D3Q28392997-4E25F2C9-ABB8-42EC-A8E8-50A6CA5878A5Q28587827-54D6ED5B-2C28-4928-A156-29DFBA214AC0Q28728249-91F42647-96F8-48D7-8F7C-0A8EFC4AEFDFQ30388923-430F77C3-04F9-4238-A74A-6E053B02B7EAQ30458465-2BCFC490-DFEB-4873-B272-7CC5468A7D25Q30640315-702900CC-6F21-4542-B44D-667475344801Q30660156-7B93147B-C6D3-40FF-AFA9-6BDDD8716D31Q30832375-50FCDF5E-94BD-4359-B7EE-C00273F578DBQ30836664-D6555E41-B3DA-483A-AD35-2F0E156956F6Q31047131-666537DE-5CE3-4A3A-A816-9F7A41E4E6B2Q33297839-35799ADC-4675-4A7B-B7CB-89906728DFFDQ33377667-375D6B59-F6EC-4D17-8BD4-533EBB488994Q33393895-170885FF-B7C4-49EB-AAEF-CD089EB7666EQ33396661-9CB96B50-C84B-49D6-B774-424C275CD8C5Q33690344-24913473-037A-437C-8AA3-E80CF2071127Q33759008-AAC528C2-82B9-4A97-A477-635C6E23C874Q33778096-6A6F2FE1-D26F-4EA6-874F-37C7490C3973Q33779694-E8F93287-935F-4606-8AAF-165D621D7FC5Q33830478-035FA15A-5233-42DF-B0FB-C96F761AF982Q33830572-BD9C8687-CA35-48A2-B32D-F4531045E969Q33926016-7118D1B5-710B-49A8-9997-646B788F1457Q33928463-6B063FDD-F0F9-4DD6-9C89-9842041E8567Q34020000-1FBA892B-30AB-4C17-A089-E714BC41F797Q34320705-1305A97F-F8FE-4773-95E6-A2091824771AQ34329654-1B40753D-4273-437B-BCC8-7D802D3EE877Q34358146-0F8664A7-E1D1-4DB9-805E-72F20EE23CEEQ34417983-96223704-6E5A-4D6A-936E-F7A0736CC679Q34418781-14B41F58-A6CF-4503-8706-1C2349B52B11Q34497951-BF0725D5-EC47-4319-8E6B-8AA54B263F36Q34659234-19477592-3C62-4B97-9CFE-F10A5246C8C9
P2860
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@ast
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@en
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@nl
type
label
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@ast
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@en
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@nl
prefLabel
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@ast
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@en
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@nl
P2093
P1476
Alzheimer's disease and the ba ...... ion, and treatment strategies.
@en
P2093
Daniel S Auld
Stéphane Bastianetto
Tom J Kornecook
P304
P356
10.1016/S0301-0082(02)00079-5
P50
P577
2002-10-01T00:00:00Z